Zobrazeno 1 - 10
of 11
pro vyhledávání: '"M. S. Stratton"'
Autor:
Frederick R. Ahmann, Patricia A. Thompson, J. Ranger-Moore, C. H. Hsu, Amit M. Algotar, S. P. Stratton, Ray B. Nagle, M. S. Stratton
Publikováno v:
Internal Medicine Journal. 42:374-380
Background: Current diagnostic tools are inadequate for reliable prediction of prostate cancer (PCa) aggressiveness in patients with localised disease. This results in many patients being exposed to potentially unnecessary invasive treatment and its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e93abf7ee23fedfa1c7d5d7bf9cbf1aa
https://doi.org/10.1111/j.1445-5994.2011.02473.x
https://doi.org/10.1111/j.1445-5994.2011.02473.x
Autor:
David S. Alberts, Mary E. Reid, M. S. Stratton, James R. Marshall, F. R. Ahmann, F. E. Minter, B. K. Monroe, G. Schwartzberg
Publikováno v:
Anti-Cancer Drugs. 14:595-600
Impediment of the promotion and progression stages of carcinogenesis of the prostate could have a profound impact on treatment choice and prognosis for prostate cancer. Efficacious chemopreventive agents that elicit their activity by slowing the proc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::036a7d83cf658adfcd0e223c704df76a
https://doi.org/10.1097/00001813-200309000-00004
https://doi.org/10.1097/00001813-200309000-00004
Autor:
F. R. Ahmann, James R. Marshall, David S. Alberts, Mary E. Reid, M. S. Stratton, B. K. Monroe, F. E. Minter, G. Schwartzberg
Publikováno v:
Anti-Cancer Drugs. 14:589-594
Epidemiological and clinical studies suggesting a significant inverse relationship between intake of dietary selenium and overall cancer risk have led to initiation of a randomized, placebo-controlled, phase III clinical trial testing the safety and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775e7050c93c39c4cb02ab7362fc8600
https://doi.org/10.1097/00001813-200309000-00003
https://doi.org/10.1097/00001813-200309000-00003
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 4, Iss 1, Pp 60-67 (2002)
The MMP, matrilysin. (20MMP-7), has been shown to be overexpressed in prostate cancer cells and to increase prostate cancer cell invasion. Prostate stromal fibroblasts secrete factor(s), including fibroblast growth factor-1. (20FGF-1) that induces pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4460f7c28825fc7a3801b8df3caf088
Autor:
Bruce L. Dalkin, Chiu Hsieh Hsu, Frederick R. Ahmann, M. S. Stratton, Steven P. Stratton, Larry C. Clark, Min Jian Xu, Ray B. Nagle, Amit M. Algotar
Although a negative association between serum selenium (or selenium supplementation) and prostate cancer risk has been widely reported (1–8), very little is known about the effects of oral supplementation with selenized yeast on selenium levels in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2bce41d831971bd410a74228f9e92ff2
https://europepmc.org/articles/PMC4526188/
https://europepmc.org/articles/PMC4526188/
Publikováno v:
The American journal of medicine. 123(8)
Background Literature indicates a relationship between selenium supplementation and risk of diabetes. However, because these data are inconclusive, we investigated the effect of selenium supplementation on serum glucose levels in men with prostate ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b005cf24bd153540246b8c59cdaf96d
https://pubmed.ncbi.nlm.nih.gov/20670733
https://pubmed.ncbi.nlm.nih.gov/20670733
Autor:
M. S. Stratton, Frederick R. Ahmann
The principal purpose of this trial is to assess the potential for the essential nutrient selenium (Se) to modulate biomarkers of prostate cancer between initial diagnostic biopsy and radical prostatectomy. The scope of work is to randomize at least
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1183bc3a6b992f494cb8207f349ca1fc
https://doi.org/10.21236/ada415790
https://doi.org/10.21236/ada415790
Publikováno v:
The Prostate. 48(3)
Background Matrix metalloproteinases (MMPs) are involved in tumor progression. Matrilysin (MMP-7) has been shown to be upregulated in prostatic carcinomas and can increase the invasive capacity of DU-145 cells. Because of the heterogenous nature of p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::838ff2f1905dd6b752986e5f8846d77d
https://pubmed.ncbi.nlm.nih.gov/11494336
https://pubmed.ncbi.nlm.nih.gov/11494336
Autor:
Amit M. Algotar, Elizabeth H. Slate, Patricia A. Thompson, P. Hsu, J. Ranger-Moore, M. S. Stratton, Steven P. Stratton, Frederick R. Ahmann
Publikováno v:
Journal of Clinical Oncology. 26:5060-5060
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e482646d08dba297e5f148cbb550f567
https://doi.org/10.1200/jco.2008.26.15_suppl.5060
https://doi.org/10.1200/jco.2008.26.15_suppl.5060